Skip to content

The Comparative Clinical Performance of Two Daily Disposable Toric Contact Lenses

The Comparative Clinical Performance of Two Daily Disposable Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05020990
Enrollment
55
Registered
2021-08-25
Start date
2022-04-01
Completion date
2023-05-02
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

This study aimed to compare the clinical performance of two daily disposable toric contact lenses.

Detailed description

This was a multi-center, randomized, participant-masked, bilateral study controlled by cross-comparison. Participants were assigned to either lens type in random sequence. Lenses were worn on a daily disposable wear schedule. Follow-up visits for each lens were performed after 1 week of wear.

Interventions

DEVICELens A (delefilcon A)

Daily disposable for one week

Daily disposable for one week

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. They are at least 18 years old and have the capacity to volunteer. 2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent. 3. They are willing and able to follow the protocol. 4. They currently wear soft contact lenses or have done so in the past two years. 5. They have a spherical component of their contact lens prescription between Plano to - 6.00DS (inclusive). 6. They have a cylindrical component of their contact lens prescription between -0.75DC and -2.50DC (inclusive). 7. They can be satisfactorily fitted with the study lens types. 8. At dispensing, they could attain at least 0.20 logMAR distance high contrast visual acuity in each eye with the study lenses within the available power range. 9. They are willing to comply with the wear schedule (at least five days per week and for at least eight hours per day). 10. They own a wearable pair of spectacles. 11. They agree not to participate in other clinical research while enrolled on this study.

Exclusion criteria

1. They have an ocular disorder which would normally contra-indicate contact lens wear. 2. They have a systemic disorder, which would normally contra-indicate contact lens wear. 3. They are using any topical medication such as eye drops or ointment. 4. They are aphakic. 5. They have had corneal refractive surgery. 6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. 7. They are pregnant or breastfeeding. 8. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear. 9. They have eye or health conditions including immunosuppressive or infectious diseases, which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction. 10. They are currently wearing one of the study contact lenses. 11. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Handling Rating on Lens RemovalOne weekSubjective handling rating on lens removal was measured on a scale of 0-100 where 0=Unmanageable and 100=Excellent removal.

Secondary

MeasureTime frameDescription
Overall Lens Fit at Follow-upOne WeekLens fit was reported as either optimum, acceptable, or unacceptable. To determine this, lens fit parameters (horizontal centration, vertical centration, corneal coverage, and lens movement) were measured on a 5-point scale (-2 to +2), where -2=Extremely nasal, 0=Optimum, and +2=Extremely temporal. Scores between -1 and +1 were considered Acceptable. For overall lens fit to be 'acceptable', no parameters could be extreme. For a score to be 'optimum', all parameters needed to be optimum.
Biomicroscopy Score at Follow-upOne weekSlit lamp biomicroscopy was used to assign grades to various biomicroscopic signs, as assessed by investigator, using Efron Grading Scales scored to the nearest 0.1 unit. Grading ranged from 0-4, where 0=None and 4=Severe.

Countries

United Kingdom

Participant flow

Recruitment details

A total of 55 participants were dispensed study lenses, and 54 completed the study. Five participants discontinued the study prior to dispensing and were therefore not included in either the enrollment count or data analysis population. Nine participants were ineligible.

Pre-assignment details

Five participants were initially ineligible, but were re-enrolled following a protocol amendment that expanded the age range and allowed the use of an increased range of lens axes for Lens A.

Participants by arm

ArmCount
Overall Study
All participants who were dispensed lenses and successfully completed the study.
54
Total54

Baseline characteristics

CharacteristicOverall Study
Age, Continuous34.6 years
STANDARD_DEVIATION 13.5
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
31 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 540 / 54
other
Total, other adverse events
5 / 541 / 54
serious
Total, serious adverse events
0 / 540 / 54

Outcome results

Primary

Subjective Handling Rating on Lens Removal

Subjective handling rating on lens removal was measured on a scale of 0-100 where 0=Unmanageable and 100=Excellent removal.

Time frame: One week

Population: Lens A: all data for one participant was discounted, as the follow-up visit took place significantly outside the date range for this visit.~Lens B: all data for a different participant was discounted, as the follow-up visit took place significantly outside the date range for this visit. Another participant's subjective scores and symptoms were not collected at the correct study visit in error, and their data was subsequently excluded from analysis.

ArmMeasureValue (MEAN)Dispersion
Lens ASubjective Handling Rating on Lens Removal85.5 units on a scaleStandard Deviation 17.7
Lens BSubjective Handling Rating on Lens Removal83.3 units on a scaleStandard Deviation 20.1
Secondary

Biomicroscopy Score at Follow-up

Slit lamp biomicroscopy was used to assign grades to various biomicroscopic signs, as assessed by investigator, using Efron Grading Scales scored to the nearest 0.1 unit. Grading ranged from 0-4, where 0=None and 4=Severe.

Time frame: One week

Population: Lens A: all data for one participant was discounted, as the follow-up visit took place significantly outside the date range for this visit.~Lens B: all data for a different participant was discounted, as the follow-up visit took place significantly outside the date range for this visit. For parameter 'mucin balls', data from an additional participant was not collected in error.

ArmMeasureGroupValue (MEAN)Dispersion
Lens ABiomicroscopy Score at Follow-upBlepharitis0.06 score on a scaleStandard Deviation 0.16
Lens ABiomicroscopy Score at Follow-upCorneal vascularisation0.05 score on a scaleStandard Deviation 0.15
Lens ABiomicroscopy Score at Follow-upMucin balls0.00 score on a scaleStandard Deviation 0
Lens ABiomicroscopy Score at Follow-upCorneal oedema0.00 score on a scaleStandard Deviation 0
Lens ABiomicroscopy Score at Follow-upLimbal hyperaemia0.63 score on a scaleStandard Deviation 0.41
Lens ABiomicroscopy Score at Follow-upCorneal staining0.23 score on a scaleStandard Deviation 0.37
Lens ABiomicroscopy Score at Follow-upPapillary conjunctivitis0.90 score on a scaleStandard Deviation 0.4
Lens ABiomicroscopy Score at Follow-upConjunctival staining0.41 score on a scaleStandard Deviation 0.44
Lens ABiomicroscopy Score at Follow-upMeibomian gland dysfunction0.16 score on a scaleStandard Deviation 0.32
Lens ABiomicroscopy Score at Follow-upConjunctival hyperaemia0.82 score on a scaleStandard Deviation 0.32
Lens BBiomicroscopy Score at Follow-upMucin balls0.10 score on a scaleStandard Deviation 0.69
Lens BBiomicroscopy Score at Follow-upPapillary conjunctivitis0.90 score on a scaleStandard Deviation 0.43
Lens BBiomicroscopy Score at Follow-upBlepharitis0.06 score on a scaleStandard Deviation 0.15
Lens BBiomicroscopy Score at Follow-upMeibomian gland dysfunction0.09 score on a scaleStandard Deviation 0.18
Lens BBiomicroscopy Score at Follow-upLimbal hyperaemia0.64 score on a scaleStandard Deviation 0.4
Lens BBiomicroscopy Score at Follow-upConjunctival hyperaemia0.76 score on a scaleStandard Deviation 0.31
Lens BBiomicroscopy Score at Follow-upCorneal vascularisation0.03 score on a scaleStandard Deviation 0.09
Lens BBiomicroscopy Score at Follow-upCorneal oedema0.00 score on a scaleStandard Deviation 0
Lens BBiomicroscopy Score at Follow-upCorneal staining0.20 score on a scaleStandard Deviation 0.32
Lens BBiomicroscopy Score at Follow-upConjunctival staining0.53 score on a scaleStandard Deviation 0.49
Secondary

Overall Lens Fit at Follow-up

Lens fit was reported as either optimum, acceptable, or unacceptable. To determine this, lens fit parameters (horizontal centration, vertical centration, corneal coverage, and lens movement) were measured on a 5-point scale (-2 to +2), where -2=Extremely nasal, 0=Optimum, and +2=Extremely temporal. Scores between -1 and +1 were considered Acceptable. For overall lens fit to be 'acceptable', no parameters could be extreme. For a score to be 'optimum', all parameters needed to be optimum.

Time frame: One Week

Population: Lens A: all data for one participant was discounted, as the follow-up visit took place significantly outside the date range for this visit.~Lens B: all data for a different participant was discounted, as the follow-up visit took place significantly outside the date range for this visit.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Lens AOverall Lens Fit at Follow-upOptimum23 Participants
Lens AOverall Lens Fit at Follow-upAcceptable53 Participants
Lens AOverall Lens Fit at Follow-upUnacceptable0 Participants
Lens BOverall Lens Fit at Follow-upUnacceptable0 Participants
Lens BOverall Lens Fit at Follow-upOptimum20 Participants
Lens BOverall Lens Fit at Follow-upAcceptable53 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026